Search Content

Showing 1 Results:

No Sales or Earnings? Don't Buy It Jan. 07, 2015

Taking Stock

Dear Mr. Berko: In January 2014, my adviser had me buy 50 shares of Intercept Pharmaceuticals at $47... Read More